London, 1st September 2003
Cancer Research Technology announces the appointment of Dr Andy Richards and Dr Celia Caulcott as Non-Executive Directors to the Board

London, 6th August 2003
Cancer Research Technology, London announces an exclusive license with GlaxoSmithKline for rights to an Oral Drug Bioavailability patent assigned from the Netherlands Cancer Institute, Amsterdam

London, 29th July 2003
Cancer Research Technology and Alnylam Pharmaceuticals Inc. announce exclusive license to patent application WO 01/36646 'Inhibiting gene expression with dsRNA' for therapeutic application.

London, 21st May 2003
Collaboration announced between Cancer Research Technology Ltd., the University of Newcastle and OSI Pharmaceuticals (UK) Ltd. on selected targets in cancer.